SCHEMBL3607802

SCHEMBL3607802

CN(C)c1ncsn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29372349 0.83
SCHEMBL30863955 0.59 HSD17B10 (0.44)
SCHEMBL4720221 0.57
Hydrochloric Acid SCHEMBL28946229 0.56 HSD17B10 (0.40)
SCHEMBL3129653 0.56 HSD17B10 (0.50)
SCHEMBL358354 0.56
Altretamine SCHEMBL4206 0.55 LMNA (1.00)
Altretamine SCHEMBL2354769 0.55 LMNA (1.00)
SCHEMBL4926690 0.54 HSD17B10 (0.54)
SCHEMBL3129639 0.54 HSD17B10 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029688-A1 BIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK SHARP & DOHME CORP. 2010-02-04 US disclosed
CN-1198822-C Angiogenesis inhibiting thiadiazolyl pyridazine derivatives JANSSEN PHARMACEUTICA B V (BE) 2005-04-27 CN disclosed
CN-1261364-A Angiogenesis inhibiting thiadiazolyl pyridazine derivatives JANSSEN PHARMACEUTICA B V (BE) 2000-07-26 CN disclosed
CN-1216527-A Method for scavenging mercaptan APOTEX INC (CA) 1999-05-12 CN disclosed
EP-0883622-A1 PROTON PUMP INHIBITOR APOTEX INC. (CA) 1998-12-16 EP disclosed
EP-0883606-A1 PROCESS FOR SCAVENGING THIOLS APOTEX INC. (CA) 1998-12-16 EP disclosed
WO-1997031923-A1 PROTON PUMP INHIBITOR APOTEX INC. (CA) 1997-09-04 WO disclosed
WO-1997031893-A1 PROCESS FOR SCAVENGING THIOLS APOTEX INC. (CA) 1997-09-04 WO disclosed